1. Stocks
    2. /
  2. J.p. Morgan Structured Products B.v. (NYSE: JPM)
    3. /

J.p. Morgan Structured Products B.v. (NYSE: JPM) Share Price and News

$316.10 $3.97 (1.3%) 5 December 2025 at 8:00:00 am AEDT

J.p. Morgan Structured Products B.v. Chart and Price Data

About JPMorgan Chase

Last updated 05-12-2025, 08:00:00am AEDT
Current Price $316.10
Change $3.97 (1.3%)
Close Price $316.10
Open Price $313.26
Bid $315.97
Ask $316.47
Day Range $313.00 - $318.49
Year Range $202.16 - $322.25
Volume 853
Average Volume 8,362,593
Market Cap $860,506,386,000.00
Earnings Per Share $20.19

    • J.p. Morgan Structured Products B.v. (NYSE: JPM)
    Latest News

    Gold

    Is there scope for Newmont shares to climb higher?

    | Marc Van Dinther

    Experts see record rally for gold and that's good news for mining ASX stock.

    Read more »

    A balance sheet and calculator for assessing a company or individual's financial position
    Resources Shares

    With $1 billion in cash on the balance sheet, should you buy Pilbara Minerals shares today?

    | Bernd Struben

    A leading expert delivers his verdict on Pilbara Minerals surging shares.

    Read more »

    A woman ponders over what to buy as she looks at the shelves of a supermarket.
    Broker Notes

    What does JP Morgan think Coles shares are worth?

    | Laura Stewart

    Coles shares are up 23% for the year to date.

    Read more »

    A man wearing a colourful shirt holds an old fashioned phone to his ear with a look of curiosity on his face as though he is pondering the answer to a question.
    Broker Notes

    What does JP Morgan think Telstra shares are worth?

    | Laura Stewart

    Can Telstra continue to beat the market from here?

    Read more »

    a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
    Retail Shares

    Down 12% in September, are Lovisa shares a buy the dip opportunity?

    | Laura Stewart

    The fast fashion retailer has soared nearly 400% in 5 years.

    Read more »

    A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
    Broker Notes

    Why does JP Morgan have an underweight rating on Wesfarmers shares?

    | Laura Stewart

    Read on to find out what's behind the rating.

    Read more »

    A group of market analysts sit and stand around their computers in an open-plan office environment.
    Broker Notes

    Down 15% from its peak, are CBA shares fully a buy according to JP Morgan?

    | Laura Stewart

    Let's find out whether CBA shares are a buy, hold or sell according to the investment bank.

    Read more »

    A happy man and woman sit having a coffee in a cafe while she holds up her phone to show him the ASX shares that did best today.
    Broker Notes

    JP Morgan initiates coverage on Sigma Healthcare shares with an overweight rating

    | Laura Stewart

    Sigma Healthcare shares have soared more than 100% in the past year.

    Read more »

    Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
    Broker Notes

    JP Morgan cuts price target on CSL shares. Are they still a buy?

    | Laura Stewart

    The ASX 200 healthcare stock fell 17% following its FY25 result.

    Read more »

    woman happy at dividends she will recieve
    Healthcare Shares

    What does JP Morgan think Resmed shares are worth after reviewing its FY25 result?

    | Laura Stewart

    Resmed shares reached a new all-time high last Friday.

    Read more »

    Man with down syndrome working in supermarket.
    Broker Notes

    JP Morgan upgrades both Coles and Woolworths shares. But which is preferred?

    | Laura Stewart

    Which company will perform better over the next 12 months?

    Read more »

    An analyst wearing a dark blue shirt and glasses sits at his computer with his chin resting on his hands as he looks at the CBA share price movement today
    Healthcare Shares

    JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?

    | Laura Stewart

    Can this ASX 200 juggernaut go higher?

    Read more »

    Profile

    since

    Note